Munafa Stock Market Course + Intraday & FNO calls 
AUROPHARMA NEWS why is Aurobindo Pharma Limited price falling or rising
AUROPHARMA NEWS reasons for why stock price of Aurobindo Pharma Limited is falling or rising
AUROPHARMA Aurobindo Pharma is falling or rising technical reasons
Technical analysis forecast of Aurobindo Pharma Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Aurobindo Pharma AUROPHARMA at this time. Stock is rising and might rise more.
It appears as if Aurobindo Pharma AUROPHARMA gave a large move recently.
Stock of Aurobindo Pharma (AUROPHARMA) is trading above an important moving average line, but it crossed this line recently, which means that it could show a small or a large fall soon enough depending on its trend.
My analysis of Aurobindo Pharma is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 1644.6 as stoploss in an intra day sell trade for a target of 1615.45. However, stock will show a bullish move above 1644.6.
AUROPHARMA Aurobindo Pharma is falling or rising NEWS fundamental reasons
Company Announcement - NEWS as on 2026-08-26
Company Announcement Aurobindo Pharma Limited has informed the Exchange about Schedule of meet - NEWS as on 2026-08-25
Company Announcement Aurobindo Pharma Limited has informed the Exchange about Completion of US FDA Inspection at Lannett Company LLC, a wholly owned subsidiary of Aurobindo Pharma USA, Inc. - NEWS as on 2026-08-24
USFDA ends inspection of Aurobindo Pharma arm's facility with 4 observations Aurobindo Pharma announced its subsidiary Lannett Company LLC's facility inspection concluded. The US Food and Drug Administration conducted this routine inspection from August 17-21, 2026. Four procedural observations were noted during the Seymour, USA fa - NEWS as on 2026-08-24 indiatimes.com
Company Announcement Aurobindo Pharma Limited has informed the Exchange about Completion of US FDA Inspection at Auro Peptides Ltd, a subsidiary/business arm of the Company. - NEWS as on 2026-08-21
Aurobindo Pharma’s Raleigh plant gets 'Voluntary Action Indicated' classification from US FDA Aurobindo Pharma's US facility received a Voluntary Action Indicated classification. The US FDA closed its inspection of the Raleigh manufacturing plant. This classification allows applications for inhalers and other products to proceed. The inspection cov - NEWS as on 2026-08-17 indiatimes.com
Company Announcement Aurobindo Pharma Limited has informed the Exchange about Transcript - NEWS as on 2026-08-14
More announcements and NEWS
AUROPHARMA Aurobindo Pharma Limited current price & indicator signals
Recent prices of AUROPHARMA Aurobindo Pharma Limited are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 27 Thu Aug 2026 | 1637.00 | 1605.70 to 1637.00 | 0.86% | 0.91 times |
| 26 Wed Aug 2026 | 1623.00 | 1611.20 to 1639.50 | 0.32% | 0.86 times |
| 25 Tue Aug 2026 | 1617.80 | 1598.80 to 1623.80 | 0.61% | 0.75 times |
| 24 Mon Aug 2026 | 1608.00 | 1604.60 to 1637.90 | -0.82% | 1.23 times |
| 21 Fri Aug 2026 | 1621.30 | 1600.00 to 1624.00 | 0.83% | 0.95 times |
| 20 Thu Aug 2026 | 1608.00 | 1602.50 to 1635.60 | -1.02% | 1.02 times |
| 19 Wed Aug 2026 | 1624.50 | 1611.70 to 1645.00 | -1.25% | 0.95 times |
| 18 Tue Aug 2026 | 1645.00 | 1626.30 to 1645.90 | 1.09% | 0.73 times |
| 17 Mon Aug 2026 | 1627.20 | 1617.90 to 1652.00 | 0.31% | 1.26 times |
| 14 Fri Aug 2026 | 1622.10 | 1621.90 to 1670.00 | -2.48% | 1.04 times |
| 13 Thu Aug 2026 | 1663.40 | 1654.50 to 1682.40 | -0.22% | 1.22 times |
| 12 Wed Aug 2026 | 1667.00 | 1652.30 to 1667.00 | 0.54% | 1.01 times |
Videos related to: AUROPHARMA NEWS why is Aurobindo Pharma Limited price falling or rising
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
